BioSpace News Archive

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

Bexson Biomedical, Inc., a company developing subcutaneously delivered therapies for pain management, addiction and mental health disorders, announced today the publication of a peer-reviewed paper in MDPI describing the company’s novel formulation technology, applied to ketamine.

Increasing incidence of ulcers have led to investments by healthcare companies in R&D initiatives to develop pressure relief devices that is expected to drive market revenue growth.

Oligon™ Inc., an emerging biotechnology company developing a novel class of multimodal RNA therapeutics for the treatment of cancer and other diseases, announced today that three abstracts have been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2022.

OncoSpark, Inc. a leader in value-based-technology enabled services, and MedicoCX, a growing startup agile team working with independent medical practices utilizing respiratory biologics, have joined forces to solve the challenge of prior authorization in the Asthma and Allergy space.

Henlius announced its annual results for the year ended December 31st, 2021, sharing the company’s recent noteworthy progress and achievements.

Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today publishes its financial results for 2021 and provides an update on its product pipeline.

Featured this week at HIMSS22, LG Electronics’ new Business Innovation Center is the first comprehensive LG technology and education hub to focus on commercial displays and devices designed for medical environments.

eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today reported financial results for the fourth quarter and year ended December 31, 2021, and provided a corporate update.

Miromatrix Medical Inc., a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced its participation in CareDx’s Xenotransplantation Innovation Day, a virtual event that will feature a leading panel of transplant experts who will share the latest advancements in the field.